Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly

Sponsor
EL Romany Ophthalmics Factory (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05699096
Collaborator
(none)
20
1
36
0.6

Study Details

Study Description

Brief Summary

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    20 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Perfluorooctyl Bromideessential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset
    Anticipated Study Start Date :
    Jul 1, 2023
    Anticipated Primary Completion Date :
    Jul 1, 2025
    Anticipated Study Completion Date :
    Jul 1, 2026

    Arms and Interventions

    Arm Intervention/Treatment
    eye surgery ,Vitreoretinal Surgery and Related Ocular Inflammation

    Outcome Measures

    Primary Outcome Measures

    1. flat the detached retina and displace the underneath fluids anteriorly [Base line]

      the effect of Perfluorooctyl Bromide on the retina ,under ophthalmic microscope check the flatted retina

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
      • Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing;
    Exclusion Criteria:
    • Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Girgis Boules Cairo Kubri EL Kubba Egypt 11711

    Sponsors and Collaborators

    • EL Romany Ophthalmics Factory

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    EL Romany Ophthalmics Factory
    ClinicalTrials.gov Identifier:
    NCT05699096
    Other Study ID Numbers:
    • ROPFO
    First Posted:
    Jan 26, 2023
    Last Update Posted:
    Jan 26, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 26, 2023